metricas
covid
Buscar en
Vacunas
Toda la web
Inicio Vacunas Lo más leído
Información de la revista

Lo más leído

797
Optic neuritis associated with COVID-19-related vaccines
Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
Vacunas. 2023;24:158-9
797
722
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspective
Farhad Dadgar, Jorge Casseb, Masoud Keikha
Vacunas. 2023;24:400-1
722
680
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, Mohammad Hossein Moieneddin, Amir Muhammad Ashrafi, ... Mostafa Rostamnezhad
Vacunas. 2023;24:141-9
680
614
Impact of vaccination on the entire population and dose-response relation of COVID-19
Abdul Malek, Ashabul Hoque
Vacunas. 2023;24:278-90
614
577
Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar?
Fernando Moraga-Llop, Magda Campins-Martí
Vacunas. 2023;24:261-5
577
551
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study
Narayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
Vacunas. 2023;24:291-7
551
520
Factores asociados a la intención de vacunación contra el COVID-19 en Popayán, Cauca, Colombia
Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Sotelo Daza, Andrés Felipe Villaquiran
Vacunas. 2023;24:174-81
520
514
Situación actual y perspectivas de futuro de las vacunas frente al virus respiratorio sincitial
Jordi Reina, Elisa Gónzalez de Herrero
Vacunas. 2023;24:150-7
514
504
COVID-19 immune response in adults post Measles-Rubella vaccination
Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
Vacunas. 2023;24:341-7
504
504
The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study
Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
Vacunas. 2023;24:273-7
504
491
Impacto de la vacunación contra SARS-CoV-2 en la incidencia de infección en ámbito escolar
María Teresa Herrero-Diez, María Inés Salado-Valdivieso, Sara Carbajal-Domínguez, Marta Allué-Tango, Juan Carlos Villa-Caballero, Clara Berbel-Hernández
Vacunas. 2023;24:203-9
491
481
Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave
Younes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad
Vacunas. 2023;24:182-9
481
475
The status of COVID-19 vaccines in India: A review
Deepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar, Niti Yashvardhini
Vacunas. 2023;24:218-47
475
464
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou
Vacunas. 2023;24:210-7
464
441
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
Vacunas. 2023;24:308-16
441
434
Vacunación antigripal universal en la infancia en España: ¿ha llegado la hora?
Josep Marès Bermúdez
Vacunas. 2023;24:55-9
434
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos